|
|
Article: NO EVIDENCE OF CARDIOVASCULAR SAFETY SIGNAL FOR PFIZER'S CELEBREX.
- Article from:
- AsiaPulse News
- Article date:
- October 4, 2004
CopyrightCOPYRIGHT 2004 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
(Full text of a statement, contact details below)
NEW YORK, Oct. 1 /PRNewswire-FirstCall-AsiaNet/ -- Pfizer Inc said today that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant safety issues and are expected to continue to completion.
The ongoing studies, which are assessing Celebrex as a potential preventative treatment in both Alzheimer's disease and colorectal cancer, have been under way at multiple medical centers worldwide for several years. The studies are being conducted by the National Cancer Institute, the National Institutes of Health and Pfizer.
The evidence ...